NCT00000232View on ClinicalTrials.gov

Alternate Day Buprenorphine Administration, Phase IX - 14

PHASE2CompletedINTERVENTIONAL
0
Timeline

Start Date

March 31, 1992

Conditions
Opioid-Related Disorders
Interventions
DRUG

Buprenorphine

Trial Locations (1)

05401

Treatment Research Center, Burlington

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

University of Vermont

OTHER